Nothing said here yet.
to join the conversation.
| Rogers CampbellChief Medical Officer | Sell | 23,933 | $1.3M | Thu, Oct 22 |
| Farquhar John C.M.Chief Executive Officer | Sell | 38,900 | $1.9M | Mon, Oct 12 |
| Rogers CampbellChief Medical Officer | Sell | 19,682 | $987.1K | Fri, Sep 18 |
| Verghese VikramChief Financial Officer | Sell | 16,766 | $850.9K | Fri, Sep 18 |
| Verghese VikramChief Financial Officer | Sell | 7,579 | $379.8K | Thu, Sep 17 |
| Verghese VikramChief Financial Officer | Sell | 668 | $33.4K | Tue, Sep 15 |
| Verghese VikramChief Financial Officer | Sell | 4,593 | $230.7K | Mon, Sep 14 |
| Verghese VikramChief Financial Officer | Sell | 29,714 | $1.5M | Fri, Sep 11 |
| Farquhar John C.M.Chief Executive Officer | Sell | 3,890 | $194.5K | Fri, Sep 11 |
| Farquhar John C.M.Chief Executive Officer | Sell | 35,010 | $1.6M | Thu, Sep 10 |
| Verghese VikramChief Financial Officer | Sell | 6,640 | $332.2K | Tue, Sep 8 |
| Verghese VikramChief Financial Officer | Sell | 27,540 | $1.4M | Thu, Sep 3 |
BOSTON, October 23, 2026--Elucid Bioimaging Inc. ("Elucid") today reaffirmed its commitment to advancing its mission – the prediction and personalization of the prevention of heart attack and stroke – and its confidence in the technology and intellectual…
Brown Capital Management, an investment management company, released its second-quarter 2026 investor letter for “The Brown Capital Management Small Company Fund.” The letter can be downloaded here.
Baron Capital, an investment management company, released its second-quarter 2026 investor letter for its “Baron SMID Cap ETF”. You can download the letter here.
The provider of an artificial intelligence-powered cardiac diagnostic platform reported a notable insider stock sale.
The medical technology company reported a notable insider sale as its shares delivered a 59% one-year return.
FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting Appropriate Use Criteria for cath lab referrals…
SAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc.
Heartflow Inc. (NASDAQ:HTFL) climbed by 46 percent week-on-week, making it the fourth-highest gainer on the stock market last week, thanks to its strong revenue performance that helped bolster its growth outlook for the full-year period.